DeAngelo, D., Walker, A., Schlenk, R., Sierra, J., Medeiros, B., Ocio, E., . . . Stuart, R. (2019). Safety and efficacy of oral panobinostat plus chemotherapy in patients aged 65 years or younger with high-risk acute myeloid leukemia.
Citación estilo ChicagoDeAngelo, DJ, et al. Safety and Efficacy of Oral Panobinostat Plus Chemotherapy in Patients Aged 65 Years or Younger With High-risk Acute Myeloid Leukemia. 2019.
Cita MLADeAngelo, DJ, et al. Safety and Efficacy of Oral Panobinostat Plus Chemotherapy in Patients Aged 65 Years or Younger With High-risk Acute Myeloid Leukemia. 2019.
Precaución: Estas citas no son 100% exactas.